Mohamad Hafizi Abu Bakar

Dr. Mohamad Hafizi Abu Bakar

Universiti Sains Malaysia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2015 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
MSMohamad Roji Sarmidi
Mohamad Roji Sarmidi
KCKian-Kai Cheng
Kian-Kai Cheng
AKAbid Ali Khan
Abid Ali Khan
CSChua Lee Suan
Chua Lee Suan
HYHarisun Yaakob
Harisun Yaakob
Metabolomic studies on obesity and type 2 diabetes mellitus have led to a number of mechanistic insights into biomarker discovery and comprehension of disease progression at metabolic levels. This article reviews a series of metabolomic studies carried out in previous and recent years on obesity and type 2 diabetes, which have shown potential metabolic biomarkers for further evaluation of the diseases. Literature including journals and books from Web of Science, Pubmed and related databases reporting on the metabolomics in these particular disorders are reviewed. We herein discuss the potential of reported metabolic biomarkers for a novel understanding of disease processes. These biomarkers include fatty acids, TCA cycle intermediates, carbohydrates, amino acids, choline and bile acids. The biological activities and aetiological pathways of metabolites of interest in driving these intricate processes are explained. The data from various publications supported metabolomics as an effective strategy in the identification of novel biomarkers for obesity and type 2 diabetes. Accelerating interest in the perspective of metabolomics to complement other fields in systems biology towards the in-depth understanding of the molecular mechanisms underlying the diseases is also well appreciated. In conclusion, metabolomics can be used as one of the alternative approaches in biomarker discovery and the novel understanding of pathophysiological mechanisms in obesity and type 2 diabetes. It can be foreseen that there will be an increasing research interest to combine metabolomics with other omics platforms towards the establishment of detailed mechanistic evidence associated with the disease processes.

18 October 2014 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
CKCheng Kian Kai
Cheng Kian Kai
WHWan Najihah Wan Hassan
Wan Najihah Wan Hassan
MSMohamad Roji Sarmidi
Mohamad Roji Sarmidi
HYHarisun Yaakob
Harisun Yaakob
HHHasniza Zaman Huri
Hasniza Zaman Huri

4 December 2017 in Apoptosis
Verified
Journal Article
Closed access
PDF file
MRMohamad Norisham Mohamad Rosdi
Mohamad Norisham Mohamad Rosdi
SAShahkila Mohd Arif
Shahkila Mohd Arif
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
SRSITI AISYAH RAZALI
SITI AISYAH RAZALI
RZRazauden Mohamed Zulkifli
Razauden Mohamed Zulkifli
HYHarisun Yaakob
Harisun Yaakob

24 February 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
TKThiruventhan Karunakaran
Thiruventhan Karunakaran
KNKok Zhuo Ngew
Kok Zhuo Ngew
AZAhmad Alif Danial Zailan
Ahmad Alif Danial Zailan
VMVIVIEN JONG MIAN
VIVIEN JONG MIAN
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkaloid has therapeutic potential for pain management as it has limited adverse effect compared to a classical opioid, morphine. Mitragynine is frequently regarded to behave like an opioid but possesses milder withdrawal symptoms. The use of this alkaloid as the source of an analgesic candidate has been proven through comprehensive preclinical and clinical studies. The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect. Moreover, the chemical and pharmacological aspects of mitragynine and its diastereomers, speciogynine, speciociliatine, and mitraciliatine, are discussed. It is interesting to know how the difference in stereochemical configuration could lead to the difference in the bioactivity of the respective compounds. Hence, in this review, the updated pharmacological and toxicological properties of mitragynine and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties of mitragynine and its diastereomers based on their structure–activity relationship study.

17 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YGYong Sean Goh
Yong Sean Goh
TKThiruventhan Karunakaran
Thiruventhan Karunakaran
VMVikneswaran Murugaiyah
Vikneswaran Murugaiyah
RSRameshkumar Santhanam
Rameshkumar Santhanam
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
SRSurash Ramanathan
Surash Ramanathan
Mitragyna speciosa Korth (kratom) is known for its psychoactive and analgesic properties. Mitragynine is the primary constituent present in kratom leaves. This study highlights the utilisation of the green accelerated solvent extraction technique to produce a better, non-toxic and antinociceptive active botanical extract of kratom. ASE M. speciosa extract had a dry yield (0.53–2.91 g) and showed a constant mitragynine content (6.53–7.19%) when extracted with organic solvents of different polarities. It only requires a shorter extraction time (5 min) and a reduced amount of solvents (less than 100 mL). A substantial amount of total phenolic (407.83 ± 2.50 GAE mg/g and flavonoids (194.00 ± 5.00 QE mg/g) were found in ASE kratom ethanol extract. The MTT test indicated that the ASE kratom ethanolic leaf extract is non-cytotoxic towards HEK-293 and HeLa Chang liver cells. In mice, ASE kratom ethanolic extract (200 mg/kg) demonstrated a better antinociceptive effect compared to methanol and ethyl acetate leaf extracts. The presence of bioactive indole alkaloids and flavonols such as mitragynine, paynantheine, quercetin, and rutin in ASE kratom ethanolic leaf extract was detected using UHPLC-ESI-QTOF-MS/MS analysis supports its antinociceptive properties. ASE ethanolic leaf extract offers a better, safe, and cost-effective choice of test botanical extract for further preclinical studies.

24 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
HSHusnul Hanani Soib
Husnul Hanani Soib
HIHassan Fahmi Ismail
Hassan Fahmi Ismail
FHFitrien Husin
Fitrien Husin
Mohamad Hafizi Abu BakarMohamad Hafizi Abu Bakar
Mohamad Hafizi Abu Bakar
HYHarisun Yaakob
Harisun Yaakob
MSMohamad Roji Sarmidi
Mohamad Roji Sarmidi
Herbal plants are traditionally utilized to treat various illnesses. They contain phytochemicals that can be extracted using conventional methods such as maceration, soxhlet, and boiling, as well as non-conventional methods including ultrasonic, microwave, and others. Carica papaya leaves have been used for the treatment of dengue, fungal, and bacterial infections as well as an ingredient in anti-aging products. Phytochemicals analysis detected the presence of kaempferol, myricetin, carpaine, pseudocarpaine, dehydrocarpaine I and II, ferulic acid, caffeic acid, chlorogenic acid, β-carotene, lycopene, and anthraquinones glycoside. Conventional preparation by boiling and simple maceration is practical, simple, and safe; however, only polar phytochemicals are extracted. The present study aims to investigate the effects of three different non-conventional extraction techniques (ultrasonic-assisted extraction, reflux, and agitation) on C. papaya phytochemical constituents, the antioxidant capacity, and wound-healing activities. Among the three techniques, the reflux technique produced the highest extraction yield (17.86%) with the presence of saponins, flavonoids, coumarins, alkaloids, and phenolic metabolites. The reflux technique also produced the highest 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging with an IC50 value of 0.236 mg/mL followed by ultrasonic-assisted extraction (UAE) (IC50: 0.377 mg/mL) and agitation (IC50: 0.404 mg/mL). At tested concentrations (3.125 µg/mL to 500 µg/mL), all extracts do not exhibit a cytotoxicity effect on the human skin fibroblast, HSF1184. Interestingly, reflux and UAE were active fibroblast proliferators that support 85% (12.5 µg/mL) and 41% (6.25 µg/mL) better cell growth, respectively. Additionally, during the early 24 h of the scratch assay, the migration rate at 12.5 µg/mL was faster for all extracts with 51.8% (reflux), 49.3% (agitation), and 42.5% (UAE) as compared to control (21.87%). At 48 h, proliferated cells covered 78.7% of the scratch area for reflux extract, 63.1% for UAE, 61% for agitation, and 42.6% for control. Additionally, the collagen synthesis was enhanced for 31.6% and 65% after 24 and 48 h of treatment for reflux. An HPLC-MS/MS-QTOF (quadruple time-of-flight) analysis of reflux identified nine phytochemicals, including carpaine, kaempferol 3-(2G-glucosylrutinoside), kaempferol 3-(2″-rhamnosylgalactoside), 7-rhamnoside, kaempferol 3-rhamnosyl-(1->2)-galactoside-7-rhamnoside, luteolin 7-galactosyl-(1->6)-galactoside, orientin 7-O-rhamnoside, 11-hydroperoxy-12,13-epoxy-9-octadecenoic acid, palmitic amide, and 2-hexaprenyl-6-methoxyphenol. The results suggested that reflux was the best technique as compared to ultrasonic and agitation.